Its commonly used for weight loss and blood sugar control, especially in women who are dealing with stubborn fat, insulin resistance, or other hormonal shifts
They work best alongside nutrition, monitoring, and medication where it is indicated
Expert Commentary and Research Insights GLP-1 Therapy Backed by Clinical Studies Brello Health's treatment approach is built on the growing body of evidence supporting GLP-1 receptor agonists, such as semaglutide and tirzepatide, for weight management
Doctors might modify other medications and monitor blood glucose frequently
It is commonly prescribed for diabetes management
And finally, prediabetic patients, regardless of the dose you essentially had about a 90-95% chance of reverting to normoglycemia with retatrutide, this is in line with tirzepatide and is just further proof that glucagon agonism isnt adding anything deleterious to blood glucose control in these patients